U.S. Markets close in 41 mins
  • S&P 500

    3,651.10
    -3.94 (-0.11%)
     
  • Dow 30

    29,169.73
    -91.08 (-0.31%)
     
  • Nasdaq

    10,833.23
    +30.31 (+0.28%)
     
  • Russell 2000

    1,662.57
    +6.69 (+0.40%)
     
  • Crude Oil

    78.58
    +1.87 (+2.44%)
     
  • Gold

    1,637.40
    +4.00 (+0.24%)
     
  • Silver

    18.40
    -0.08 (-0.46%)
     
  • EUR/USD

    0.9594
    -0.0018 (-0.1823%)
     
  • 10-Yr Bond

    3.9640
    +0.0860 (+2.22%)
     
  • Vix

    33.07
    +0.81 (+2.51%)
     
  • GBP/USD

    1.0723
    +0.0040 (+0.3710%)
     
  • USD/JPY

    144.8360
    +0.1560 (+0.1078%)
     
  • BTC-USD

    19,139.73
    -29.03 (-0.15%)
     
  • CMC Crypto 200

    438.94
    -20.20 (-4.40%)
     
  • FTSE 100

    6,984.59
    -36.36 (-0.52%)
     
  • Nikkei 225

    26,571.87
    +140.32 (+0.53%)
     

Stellantis Registers 17% Revenue Growth In 1H22

·1 min read
  • Stellantis NV (NYSE: STLAreported the first half FY22 revenues of €88.0 billion, up 17% from 1H21 Pro Forma revenues, reflecting strong net pricing, favorable vehicle mix, and positive FX translation effects.

  • North America's revenue rose 30.8% Y/Y to €42.4 billion, South America increased 46.5% to €7.2 billion, Europe fell 2.3% to €31.3 billion, Middle East & Africa rose 19.3% to €3 billion, China and India & Asia Pacific grew 14.3% to €2.2 billion.

  • The adjusted operating margin expanded 270 basis points to 14.1%, and the adjusted operating income was €12.4 billion.

  • Cash flow from operating activities totaled €9.8 billion.

  • It reported Industrial free cash flows of €5.3 billion.

  • Global BEV sales are up nearly 50% Y/Y to 136,000 units.

  • Outlook: Stellantis sees FY22 adjusted operating income margin to be in double-digits.

  • Price Action: STLA shares are trading higher by 3.88% at $13.91 on the last check Thursday.

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.